{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:46:34Z","timestamp":1793015194335,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.heliyon.2023.e20495","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T11:55:46Z","timestamp":1697802946000},"page":"e20495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["\u201cEfficacy and safety of oteseconazole in recurrent vulvovaginal candidiasis (RVVC) \u2013 A systematic review and meta-analysis\""],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1620-5102","authenticated-orcid":false,"given":"Tasmiyah","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6647-0270","authenticated-orcid":false,"given":"Kanwal Ashok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal Rani","family":"Doultani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4957-4817","authenticated-orcid":false,"given":"Tayyaba","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1667-0418","authenticated-orcid":false,"given":"Farea","family":"Eqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samrah Inam","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e20495_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.325.7364.586","article-title":"Extracts from \u201cconcise clinical evidence\u201d: vulvovaginal candidiasis","volume":"325","author":"Marrazzo","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2023.e20495_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajog.2015.06.067","article-title":"Recurrent vulvovaginal candidiasis","volume":"214","author":"Sobel","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.heliyon.2023.e20495_bib3","first-page":"238","article-title":"Prevalence of non-albicans Candida infections in women with recurrent vulvovaginal symptomatology","volume":"3","author":"Mintz","year":"2013","journal-title":"Adv. Infect. Dis."},{"key":"10.1016\/j.heliyon.2023.e20495_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/jof4040121","article-title":"An update on the roles of non-albicans Candida species in vulvovaginitis","volume":"4","author":"Makanjuola","year":"2018","journal-title":"Journal of Fungi"},{"key":"10.1016\/j.heliyon.2023.e20495_bib5","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1016\/S1473-3099(18)30103-8","article-title":"Global burden of recurrent vulvovaginal candidiasis: a systematic review","volume":"18","author":"Denning","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.heliyon.2023.e20495_bib6","unstructured":"Vulvovaginal Candidiasis - STI Treatment Guidelines, (n.d.).1-3 https:\/\/www.cdc.gov\/std\/treatment-guidelines\/candidiasis.htm (accessed July 6, 2023)."},{"key":"10.1016\/j.heliyon.2023.e20495_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2023.e20495_bib8","series-title":"Fluconazole, Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs","first-page":"2756","author":"Govindarajan","year":"2023"},{"key":"10.1016\/j.heliyon.2023.e20495_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/LGT.0000000000000496","article-title":"Prognosis and long-term outcome of women with idiopathic recurrent vulvovaginal candidiasis caused by Candida albicans","volume":"24","author":"Collins","year":"2020","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.heliyon.2023.e20495_bib10","unstructured":"FDA, CDER, Highlights of Prescribing Information, (n.d.), 1\u201313.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215888s000lbl.pdf (accessed July 6, 2023)."},{"key":"10.1016\/j.heliyon.2023.e20495_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2023.e20495_bib12","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.heliyon.2023.e20495_bib13","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100055","article-title":"Efficacy and safety of oteseconazole in recurrent vulvovaginal candidiasis","volume":"1","author":"Sobel","year":"2022","journal-title":"NEJM Evidence"},{"key":"10.1016\/j.heliyon.2023.e20495_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2022.07.023","article-title":"Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections","volume":"227","author":"Martens","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.heliyon.2023.e20495_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejogrb.2012.12.001","article-title":"Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis","volume":"167","author":"Rosa","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.heliyon.2023.e20495_bib16","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s40265-022-01734-y","article-title":"Oteseconazole: first approval","volume":"82","author":"Hoy","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.heliyon.2023.e20495_bib17","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/ajhp\/zxac247","volume":"79","author":"Oteseconazole","year":"2022","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.heliyon.2023.e20495_bib18","doi-asserted-by":"crossref","first-page":"E1518","DOI":"10.1093\/cid\/ciaa1204","article-title":"A randomized phase 2 study of VT-1161 for the treatment of acute vulvovaginal candidiasis","volume":"73","author":"Brand","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2023.e20495_bib19","unstructured":"Fda, Cder, DIFLUCAN \u00ae (Fluconazole Tablets) (Fluconazole Injection-For Intravenous Infusion Only) (Fluconazole for Oral Suspension), (n.d.)."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023077034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023077034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:17:33Z","timestamp":1791292653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023077034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2405844023077034"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20495","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cEfficacy and safety of oteseconazole in recurrent vulvovaginal candidiasis (RVVC) \u2013 A systematic review and meta-analysis\"","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e20495"}}